# FDA 483 - Johnson & Johnson Consumer Inc - August 12, 2010

Source: https://www.keypedia.com/records/483/johnson-johnson-consumer-inc/1ad5f0ba-04db-4153-9c1d-1e2d2fedec02

> FDA 483 for Johnson & Johnson Consumer Inc on August 12, 2010. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Johnson & Johnson Consumer Inc
- Inspection Date: 2010-08-12
- Product Type: drugs
- Office Name: Division of Pharmaceutical Quality Operations IV
- Summary: An FDA inspection of Neutrogena Corporation in Los Angeles, CA, revealed a significant quality control deficiency. The firm failed to ensure that drug product production and control records were adequately reviewed by the quality control unit before batch release. Specifically, temperature excursions during mixing for Body Clear Body Wash lots were not identified during batch record review.

## Related Documents

- [EIR - 2020-03-11](https://www.keypedia.com/records/eir/johnson-johnson-consumer-inc/894de33b-ec70-4292-bcb4-2c5c93948fbd)

## Related Officers

- [Investigator](https://www.keypedia.com/people/truong-x-nguyen/8f3aed17-0507-4272-a3b8-9188d761faed)

Company: https://www.keypedia.com/companies/johnson-johnson-consumer-inc/8f348929-c130-43c6-9115-3a609fb0d9d6

Office: https://www.keypedia.com/offices/division-of-pharmaceutical-quality-operations-iv/a2d2ff91-dc0f-433e-b91f-ca90ff8998b6